ARWR vs MSFT: Which Stock is Better?
Side-by-side comparison of Arrowhead Pharmaceuticals Inc and Microsoft Corp in 2026
ARWR
Arrowhead Pharmaceuticals Inc
$70.53
MSFT
Microsoft Corp
$417.51
Key Metrics Comparison
| Metric | ARWR | MSFT | Winner |
|---|---|---|---|
| Market Cap | $9.82B | N/A | ARWR |
| P/E Ratio | 43.83 | 26.60 | MSFT |
| EPS (TTM) | $1.60 | $16.14 | MSFT |
| Revenue Growth | 104.6% | 0.2% | ARWR |
| Gross Margin | 100.0% | 68.6% | ARWR |
Analyze ARWR
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARWR or MSFT a better investment?
Comparing ARWR and MSFT: Arrowhead Pharmaceuticals Inc has a market cap of $9.82B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARWR and MSFT?
ARWR (Arrowhead Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARWR or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (26.6x vs 43.8x).
Which is growing faster: ARWR or MSFT?
ARWR has higher revenue growth at 104.6% vs 0.2% for MSFT.
Which company is more profitable: ARWR or MSFT?
Arrowhead Pharmaceuticals Inc (ARWR) has higher gross margins at 100.0% compared to 68.6% for MSFT.
Which is the larger company: ARWR or MSFT?
Arrowhead Pharmaceuticals Inc (ARWR) is larger with a market cap of $9.82B compared to N/A for MSFT.
Should I buy ARWR or MSFT in 2026?
Both ARWR and MSFT have investment merit. ARWR trades at $70.53 while MSFT trades at $417.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARWR and MSFT stock?
Key differences: Market Cap ($9.82B vs N/A), P/E Ratio (43.8x vs 26.6x), Revenue Growth (104.6% vs 0.2%), Gross Margin (100.0% vs 68.6%).